Report of Foreign Issuer (6-k)
August 25 2020 - 7:05AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of August 2020
Commission File Number: 001-36349
MediWound Ltd.
(Translation of registrant’s name into English)
42 Hayarkon Street
Yavne, 8122745 Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(7): ☐
EXPLANATORY NOTE
On August 25, 2020, MediWound Ltd. (the “Company”) issued a press release entitled “MediWound and Vericel Announce
Acceptance of the First Delivery of NexoBrid to BARDA for Emergency Response Preparedness”. A copy of this press release is attached to this Form 6-K as Exhibit 99.1.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
|
MEDIWOUND LTD.
|
|
|
|
|
|
Date: August 25, 2020
|
By:
|
/s/ Boaz Gur-Lavie
|
|
|
|
Name: Boaz Gur-Lavie
|
|
|
|
Title: Chief Financial Officer
|
|
|
|
|
|
3
EXHIBIT INDEX
The following exhibit is filed as part of this Form 6-K:
4
MediWound (NASDAQ:MDWD)
Historical Stock Chart
From Mar 2024 to Apr 2024
MediWound (NASDAQ:MDWD)
Historical Stock Chart
From Apr 2023 to Apr 2024